Coronary revascularization (ANGIO or CABG)

I9_REVASC

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

25449

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

24661

diagram downward connector
I9_REVASC

Control definitions

Control exclude I9_ISCHHEART

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 24661 5838 18823
Unadjusted prevalence (%) 5.99 2.54 10.36
Mean age at first event (years) 64.43 65.83 64.00

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.21 [1.95, 2.50] 1.4e-36 7583
15 years 0.01 1.71 [1.56, 1.88] 1.5e-28 3986
5 years 0.00 2.04 [1.87, 2.23] 5.2e-55 1549
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: I9_REVASC – Coronary revascularization (ANGIO or CABG)
GWS hits: 111

Survival analyses between endpoints

Plot

before Coronary revascularization (ANGIO or CABG)
after Coronary revascularization (ANGIO or CABG)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Coronary revascularization (ANGIO or CABG)

Endpoint not on priority list, no data to show.